{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:25:31Z","timestamp":1790040331476,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of the Xinjiang Uygur Autonomous Region","award":["2022D01C185"],"award-info":[{"award-number":["2022D01C185"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73146-9","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T11:00:00Z","timestamp":1726743600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Analysis of vaginal flora diversity and study on the role of Porphyromonas asaccharolytica in promoting IL-1\u03b2 in regulating cervical cancer"],"prefix":"10.1038","volume":"14","author":[{"given":"Bing","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulixian","family":"Tuerxun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awahan","family":"Tuerdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rexianguli","family":"Maimaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azierguli","family":"Abudukerimu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"73146_CR1","doi-asserted-by":"crossref","unstructured":"1. Miranda, P.J.C., et al., Correlation between human papillomavirus infection and histopathological diagnosis of women in Northeast Brazil. J Med Virol, 2020. 92(12): p. 3799\u20133806.","DOI":"10.1002\/jmv.26101"},{"key":"73146_CR2","doi-asserted-by":"crossref","unstructured":"2. Chen, X., et al., NAT10\/ac4C\/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer. Adv Sci (Weinh), 2023. 10(32): p. e2302705.","DOI":"10.1002\/advs.202302705"},{"key":"73146_CR3","doi-asserted-by":"crossref","unstructured":"3. Sharma, K., et al., No woman left behind: achieving cervical cancer elimination among women living with HIV. Lancet HIV, 2023. 10(6): p. e412-e420.","DOI":"10.1016\/S2352-3018(23)00082-6"},{"key":"73146_CR4","doi-asserted-by":"crossref","unstructured":"4. Mix, J., et al., Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management. J Natl Cancer Inst, 2022. 114(6): p. 845\u2013853.","DOI":"10.1093\/jnci\/djac034"},{"key":"73146_CR5","doi-asserted-by":"crossref","unstructured":"5. Kreimer, A.R., et al., Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule. J Natl Cancer Inst, 2023. 115(3): p. 246\u2013249.","DOI":"10.1093\/jnci\/djac189"},{"key":"73146_CR6","doi-asserted-by":"crossref","unstructured":"6. Hu, Z. and D. Ma, The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Med, 2018. 7(10): p. 5217\u20135236.","DOI":"10.1002\/cam4.1501"},{"key":"73146_CR7","doi-asserted-by":"crossref","unstructured":"7. Hu, Z., et al., TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy. J Clin Invest, 2015. 125(1): p. 425\u2009\u2212\u200936.","DOI":"10.1172\/JCI78206"},{"key":"73146_CR8","doi-asserted-by":"crossref","unstructured":"8. Elfstr\u00f6m, K.M., et al., Cervical cancer screening in Europe: Quality assurance and organisation of programmes. Eur J Cancer, 2015. 51(8): p. 950\u2009\u2212\u200968.","DOI":"10.1016\/j.ejca.2015.03.008"},{"key":"73146_CR9","doi-asserted-by":"crossref","unstructured":"9. Skeate, J.G., et al., Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases. Hum Vaccin Immunother, 2016. 12(6): p. 1418-29.","DOI":"10.1080\/21645515.2015.1136039"},{"key":"73146_CR10","doi-asserted-by":"crossref","unstructured":"10. Levin, C., et al., An Extended Cost-Effectiveness Analysis of Publicly Financed HPV Vaccination to Prevent Cervical Cancer in China, in Cancer: Disease Control Priorities, Third Edition (Volume 3), H. Gelband, et al., Editors. 2015, The International Bank for Reconstruction and Development \/ The World Bank \u00a9 2015 International Bank for Reconstruction and Development \/ The World Bank.: Washington (DC).","DOI":"10.1596\/978-1-4648-0349-9_ch18"},{"key":"73146_CR11","doi-asserted-by":"crossref","unstructured":"11. Zhai, L. and E. Tumban, Gardasil-9: A global survey of projected efficacy. Antiviral Res, 2016. 130: p. 101-9.","DOI":"10.1016\/j.antiviral.2016.03.016"},{"key":"73146_CR12","doi-asserted-by":"crossref","unstructured":"12. Son, S.H., et al., Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent Chemoradiotherapy. Clin Nucl Med, 2018. 43(9): p. e296-e303.","DOI":"10.1097\/RLU.0000000000002188"},{"key":"73146_CR13","doi-asserted-by":"crossref","unstructured":"13. Monk, B.J., et al., Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials. Cancer Treat Rev, 2022. 106: p. 102385.","DOI":"10.1016\/j.ctrv.2022.102385"},{"key":"73146_CR14","doi-asserted-by":"crossref","unstructured":"14. Dan, Z., et al., Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder. Gut Microbes, 2020. 11(5): p. 1246\u20131267.","DOI":"10.1080\/19490976.2020.1747329"},{"key":"73146_CR15","doi-asserted-by":"crossref","unstructured":"15. Stasiewicz, M. and T.M. Karpi\u0144ski, The oral microbiota and its role in carcinogenesis. Semin Cancer Biol, 2022. 86(Pt 3): p. 633\u2013642.","DOI":"10.1016\/j.semcancer.2021.11.002"},{"key":"73146_CR16","doi-asserted-by":"crossref","unstructured":"16. Chen, C., et al., The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nat Commun, 2017. 8(1): p. 875.","DOI":"10.1038\/s41467-017-00901-0"},{"key":"73146_CR17","doi-asserted-by":"crossref","unstructured":"17. Yang, Y., et al., Dysbiosis of human gut microbiome in young-onset colorectal cancer. Nature Communications, 2021. 12(1).","DOI":"10.1038\/s41467-021-27112-y"},{"key":"73146_CR18","doi-asserted-by":"crossref","unstructured":"18. Qi, X., et al., Gut microbiota\u2013bile acid\u2013interleukin-22 axis orchestrates polycystic ovary syndrome. Nature Medicine, 2019. 25(8): p. 1225\u20131233.","DOI":"10.1038\/s41591-019-0509-0"},{"key":"73146_CR19","doi-asserted-by":"crossref","unstructured":"19. Kyrgiou, M. and A.B. Moscicki, Vaginal microbiome and cervical cancer. Semin Cancer Biol, 2022. 86(Pt 3): p. 189\u2013198.","DOI":"10.1016\/j.semcancer.2022.03.005"},{"key":"73146_CR20","doi-asserted-by":"crossref","unstructured":"20. Romero-Morelos, P., et al., Vaginosis-associated bacteria and its association with HPV infection. Med Clin (Barc), 2019. 152(1): p. 1\u20135.","DOI":"10.1016\/j.medcle.2018.11.005"},{"key":"73146_CR21","doi-asserted-by":"crossref","unstructured":"21. Wu, S., et al., The feature of cervical microbiota associated with the progression of cervical cancer among reproductive females. Gynecol Oncol, 2021. 163(2): p. 348\u2013357.","DOI":"10.1016\/j.ygyno.2021.08.016"},{"key":"73146_CR22","doi-asserted-by":"crossref","unstructured":"22. Clarke, M.A., et al., A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection. BMC Infect Dis, 2012. 12: p. 33.","DOI":"10.1186\/1471-2334-12-33"},{"key":"73146_CR23","doi-asserted-by":"crossref","unstructured":"23. Ghosh, I., et al., Association between high risk human papillomavirus infection and co-infection with Candida spp. and Trichomonas vaginalis in women with cervical premalignant and malignant lesions. J Clin Virol, 2017. 87: p. 43\u201348.","DOI":"10.1016\/j.jcv.2016.12.007"},{"key":"73146_CR24","doi-asserted-by":"crossref","unstructured":"24. Callahan, B.J., et al., High-throughput amplicon sequencing of the full-length 16S rRNA gene with single-nucleotide resolution. Nucleic Acids Res, 2019. 47(18): p. e103.","DOI":"10.1093\/nar\/gkz569"},{"key":"73146_CR25","doi-asserted-by":"crossref","unstructured":"25. Bolyen, E., et al., Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol, 2019. 37(8): p. 852\u2013857.","DOI":"10.1038\/s41587-019-0209-9"},{"key":"73146_CR26","doi-asserted-by":"crossref","unstructured":"26. Witkin, S.S. and I.M. Linhares, Why do lactobacilli dominate the human vaginal microbiota? Bjog, 2017. 124(4): p. 606\u2013611.","DOI":"10.1111\/1471-0528.14390"},{"key":"73146_CR27","doi-asserted-by":"crossref","unstructured":"27. Farr Zuend, C., et al., Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus. Microbiome, 2023. 11(1): p. 159.","DOI":"10.1186\/s40168-023-01594-y"},{"key":"73146_CR28","doi-asserted-by":"crossref","unstructured":"28. Witkin, S.S., et al., Influence of Lactobacillus crispatus, Lactobacillus iners and Gardnerella vaginalis on bacterial vaginal composition in pregnant women. Arch Gynecol Obstet, 2021. 304(2): p. 395\u2013400.","DOI":"10.1007\/s00404-021-05978-z"},{"key":"73146_CR29","doi-asserted-by":"crossref","unstructured":"29. Wright, M.L., et al., Vaginal microbiome Lactobacillus crispatus is heritable among European American women. Communications Biology, 2021. 4(1).","DOI":"10.1038\/s42003-021-02394-6"},{"key":"73146_CR30","doi-asserted-by":"crossref","unstructured":"30. Ahire, J.J., et al., In Vitro Assessment of Lactobacillus crispatus UBLCp01, Lactobacillus gasseri UBLG36, and Lactobacillus johnsonii UBLJ01 as a Potential Vaginal Probiotic Candidate. Probiotics Antimicrob Proteins, 2023. 15(2): p. 275\u2013286.","DOI":"10.1007\/s12602-021-09838-9"},{"key":"73146_CR31","doi-asserted-by":"crossref","unstructured":"31. Sundstrom, B., et al., A reproductive justice approach to understanding women\u2019s experiences with HPV and cervical cancer prevention. Soc Sci Med, 2019. 232: p. 289\u2013297.","DOI":"10.1016\/j.socscimed.2019.05.010"},{"key":"73146_CR32","doi-asserted-by":"crossref","unstructured":"32. Bhatla, N. and S. Singhal, Primary HPV screening for cervical cancer. Best Pract Res Clin Obstet Gynaecol, 2020. 65: p. 98\u2013108.","DOI":"10.1016\/j.bpobgyn.2020.02.008"},{"key":"73146_CR33","doi-asserted-by":"crossref","unstructured":"33. Guo, X., et al., Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study. JAMA Surg, 2020. 155(7): p. 572\u2013579.","DOI":"10.1001\/jamasurg.2020.1133"},{"key":"73146_CR34","doi-asserted-by":"crossref","unstructured":"34. Mitra, A., et al., The vaginal microbiota and innate immunity after local excisional treatment for cervical intraepithelial neoplasia. Genome Med, 2021. 13(1): p. 176.","DOI":"10.1186\/s13073-021-00977-w"},{"key":"73146_CR35","doi-asserted-by":"crossref","unstructured":"35. Belleti, R., et al., Cervicovaginal loads of Gardnerella spp. are increased in immunocompetent women with persistent high-risk human papillomavirus infection. J Med Microbiol, 2022. 71(5).","DOI":"10.1099\/jmm.0.001527"},{"key":"73146_CR36","doi-asserted-by":"crossref","unstructured":"36. Lithgow, K.V., et al., Protease activities of vaginal Porphyromonas species disrupt coagulation and extracellular matrix in the cervicovaginal niche. npj Biofilms and Microbiomes, 2022. 8(1).","DOI":"10.1038\/s41522-022-00270-7"},{"key":"73146_CR37","doi-asserted-by":"crossref","unstructured":"37. Takeuchi, H., et al., Porphyromonas gingivalis induces penetration of lipopolysaccharide and peptidoglycan through the gingival epithelium via degradation of junctional adhesion molecule 1. PLoS Pathog, 2019. 15(11): p. e1008124.","DOI":"10.1371\/journal.ppat.1008124"},{"key":"73146_CR38","doi-asserted-by":"crossref","unstructured":"38. Xie, M., et al., Porphyromonas gingivalis disrupts vascular endothelial homeostasis in a TLR-NF-\u03baB axis dependent manner. Int J Oral Sci, 2020. 12(1): p. 28.","DOI":"10.1038\/s41368-020-00096-z"},{"key":"73146_CR39","doi-asserted-by":"crossref","unstructured":"39. Ao, M., et al., Dental Infection of Porphyromonas gingivalis Induces Preterm Birth in Mice. PLoS One, 2015. 10(8): p. e0137249.","DOI":"10.1371\/journal.pone.0137249"},{"key":"73146_CR40","doi-asserted-by":"crossref","unstructured":"40. Wen, Z.T., et al., Streptococcus mutans Displays Altered Stress Responses While Enhancing Biofilm Formation by Lactobacillus casei in Mixed-Species Consortium. Front Cell Infect Microbiol, 2017. 7: p. 524.","DOI":"10.3389\/fcimb.2017.00524"},{"key":"73146_CR41","doi-asserted-by":"crossref","unstructured":"41. Andersen, K., et al., Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation. J Am Soc Nephrol, 2017. 28(1): p. 76\u201383.","DOI":"10.1681\/ASN.2015111285"},{"key":"73146_CR42","doi-asserted-by":"crossref","unstructured":"42. Hanahan, D., Hallmarks of Cancer: New Dimensions. Cancer Discovery, 2022. 12(1): p. 31\u201346.","DOI":"10.1158\/2159-8290.CD-21-1059"},{"key":"73146_CR43","doi-asserted-by":"crossref","unstructured":"43. Guo, Y.L., et al., Bacterial vaginosis is conducive to the persistence of HPV infection. Int J STD AIDS, 2012. 23(8): p. 581-4.","DOI":"10.1258\/ijsa.2012.011342"},{"key":"73146_CR44","unstructured":"44. Wang, J., et al., [The optimal model of diagnosis to low-grade cervical intraepithelial neoplasia by combined detecting vaginal micro-environmental factors, based on the high-risk HPV infection]. Zhonghua Liu Xing Bing Xue Za Zhi, 2021. 42(6): p. 1108\u20131112."},{"key":"73146_CR45","doi-asserted-by":"crossref","unstructured":"45. Ntuli, L., et al., Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection. Front Cell Infect Microbiol, 2022. 12: p. 927131.","DOI":"10.3389\/fcimb.2022.927131"},{"key":"73146_CR46","doi-asserted-by":"crossref","unstructured":"46. Tachedjian, G., et al., The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res Microbiol, 2017. 168(9\u201310): p. 782\u2013792.","DOI":"10.1016\/j.resmic.2017.04.001"},{"key":"73146_CR47","doi-asserted-by":"crossref","unstructured":"47. De Vecchi, E., et al., Alpha defensin, leukocyte esterase, C-reactive protein, and leukocyte count in synovial fluid for pre-operative diagnosis of periprosthetic infection. Int J Immunopathol Pharmacol, 2018. 32: p. 2058738418806072.","DOI":"10.1177\/2058738418806072"},{"key":"73146_CR48","doi-asserted-by":"crossref","unstructured":"48. Mann, M., V.P. Singh, and L. Kumar, Cervical cancer: a tale from HPV infection to PARP inhibitors. Genes Dis, 2023. 10(4): p. 1445\u20131456.","DOI":"10.1016\/j.gendis.2022.09.014"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73146-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73146-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73146-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T11:21:15Z","timestamp":1726744875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73146-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73146"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73146-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research received approval from the Xinjiang Medical University institutional review board (Ethical approval number XJYKDXR20211015003. Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"21731"}}